Effect of Optimal Positive End-Expiratory Pressure on Oxygenation and Intrapulmonary Shunt During One-lung Ventilation
NCT ID: NCT03804398
Last Updated: 2019-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2018-06-14
2018-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury
NCT01581229
Epidemiology and Treatment Strategy of Open Respiratory Phenotype in Critically Ill Patients
NCT06393179
The Effect of Positive End Expiratory Pressure on Central Venous Pressure Among Patients With Different Lung Compliance
NCT03341572
Respiratory Function Monitoring of Mechanical Ventilation in Patients With Chest Blunt Injury
NCT06386120
Different PEEP Settings of COVID-19 Induced ARDS
NCT04359251
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
optimal PEEP group
The study group titrate PEEP from 4cmH2O,increased in 2cmH2O steps and hold at each step for 1min,and the static pulmonary compliance(Cst) would be record.Optimal PEEP was determined until the maximal static pulmonary compliance was obtained
compliance guided an optimal Positive End-Expiratory Pressure
The study groups received an alveolar recruitment maneuver(increase inspiratory pressure to 30cmH2O for 10s) at the 10min after one-lung ventilation. After the alveolar recruitment maneuver,the study group titrate PEEP from 4cmH2O,increased in 2cmH2O steps and hold at each step for 1min,and the static pulmonary compliance(Cst) would be record.Optimal PEEP was determined until the maximal static pulmonary compliance was obtained.
PEEP level of 5 cmH2O group
In the control group at PEEP level of 5 cmH2O was established and maintained during the study period
PEEP level of 5 cmH2O
In the control group at PEEP level of 5 cmH2O was established and maintained during the study period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
compliance guided an optimal Positive End-Expiratory Pressure
The study groups received an alveolar recruitment maneuver(increase inspiratory pressure to 30cmH2O for 10s) at the 10min after one-lung ventilation. After the alveolar recruitment maneuver,the study group titrate PEEP from 4cmH2O,increased in 2cmH2O steps and hold at each step for 1min,and the static pulmonary compliance(Cst) would be record.Optimal PEEP was determined until the maximal static pulmonary compliance was obtained.
PEEP level of 5 cmH2O
In the control group at PEEP level of 5 cmH2O was established and maintained during the study period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index(BMI)18-28kg/m2
* American Society of Anesthesiologists Physical Status Classifications I to II
* Normal cardiac and pulmonary function
* Diagnosed with uncomplicated lung cancer and was to receive video-assist thoracoscopic lobectomy under general anesthesia.
Exclusion Criteria
* Asthma
* Chronic obstructive pulmonary disease
* Acute lung infection
* Past history of thoracic surgery
* Cardiac,hepatic,renal and endocrine diseases
* Preoperative glucocorticoid medication
* Preoperative chemotherapy
* Peripheral oxygen saturation(SpO2) kept below 90% for more than 10 minutes during operation
* Blood transfusion during operation
* Duration of one-lung ventilation less than an hour
* Occurrence of severe complications like allergic shock
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fujian Medical University Union Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wenhua chen
Role: PRINCIPAL_INVESTIGATOR
Fujian Medical University Union Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
FujianUnionHospital
Fuzhou, Fujian, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FujianUnionAnethesiaOne
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.